Docusign (NASDAQ:DOCU) Receives “Buy” Rating from BTIG Research

Docusign (NASDAQ:DOCU)‘s stock had its “buy” rating restated by BTIG Research in a report issued on Wednesday,Benzinga reports. They presently have a $70.00 target price on the stock. BTIG Research’s target price points to a potential upside of 47.24% from the stock’s current price.

A number of other research firms also recently weighed in on DOCU. Robert W. Baird dropped their price target on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Zacks Research cut Docusign from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. UBS Group decreased their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Wells Fargo & Company lowered their target price on Docusign from $85.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Friday, December 5th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Five research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat, Docusign has a consensus rating of “Hold” and an average target price of $78.80.

Docusign Stock Up 1.5%

Docusign stock opened at $47.54 on Wednesday. The company has a market capitalization of $9.52 billion, a PE ratio of 33.24, a PEG ratio of 2.04 and a beta of 1.03. Docusign has a 12-month low of $40.16 and a 12-month high of $94.67. The firm’s fifty day moving average is $51.11 and its 200 day moving average is $64.46.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.57% and a return on equity of 15.02%. The business had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. During the same period last year, the company posted $0.86 earnings per share. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Sell-side analysts expect that Docusign will post 1.17 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CRO Paula Hansen sold 6,000 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the completion of the sale, the executive owned 68,970 shares in the company, valued at $4,624,438.50. This represents a 8.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the transaction, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. The trade was a 18.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 51,477 shares of company stock valued at $3,521,607 in the last 90 days. Insiders own 1.66% of the company’s stock.

Hedge Funds Weigh In On Docusign

A number of hedge funds and other institutional investors have recently modified their holdings of DOCU. Centaurus Financial Inc. grew its holdings in shares of Docusign by 2.6% in the second quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares in the last quarter. Mitchell & Pahl Private Wealth LLC lifted its holdings in Docusign by 0.7% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock worth $1,544,000 after acquiring an additional 149 shares during the period. EverSource Wealth Advisors LLC boosted its position in Docusign by 15.1% in the third quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock worth $89,000 after purchasing an additional 161 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after purchasing an additional 165 shares during the last quarter. Finally, Americana Partners LLC grew its stake in Docusign by 3.3% in the 3rd quarter. Americana Partners LLC now owns 5,467 shares of the company’s stock valued at $394,000 after purchasing an additional 176 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results beat consensus — adjusted EPS $1.01 vs. $0.95 expected and revenue $836.9M beating estimates; strong execution drove the immediate market reaction. DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Guidance and outlook skew positive — revenue guidance midpoint for next quarter was slightly above Street expectations, signaling management confidence in growth into FY27. DocuSign’s (NASDAQ:DOCU) Q4 CY2025: Beats On Revenue, Outlook For Next Year Is Optimistic
• Positive Sentiment: Board-authorized buyback expansion — DocuSign raised its share repurchase program by $2.0 billion, a tangible capital-return action that reduces float and supports EPS. DocuSign Announces Fourth Quarter and Fiscal Year 2026 Financial Results; Announces $2.0 Billion Increase to Share Repurchase Program
• Positive Sentiment: AI and product momentum — management credited growth to its AI-enabled agreement platform, and the company is targeting an 18% IAM ARR share in FY2027 while expanding AI partnerships, reinforcing the narrative of growth beyond e-signatures. Docusign targets 18 percent IAM ARR share in fiscal 2027 while expanding AI partnerships
• Neutral Sentiment: Earnings call and disclosures available — full transcript, slide deck and prepared remarks provide additional detail for investors to assess churn, deal sizes and AI adoption rates. Docusign, Inc. (DOCU) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Valuation and competitive risks highlighted — some analysts trimmed fair value and warned that AI competition, pricing tests and slowing long-term growth could cap upside, keeping downward pressure on multiples. How The DocuSign (DOCU) Story Is Shifting As AI Risks Meet New Pricing Tests
• Negative Sentiment: Bearish commentary on downside risk — some market pieces warned the stock remains vulnerable after a multi-month pullback and could face steep downside if growth disappoints. DocuSign stock price at risk of a steep crash after earnings on March 17

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.